Systemic cancer therapies
Chemotherapy, immunotherapy, targeted drugs and hormonal treatment act differently. Eligibility, blood monitoring, cycle intervals and support between visits depend on the prescribed regimen.
Treatments in this specialty
Procedure guides
Times are planning guides, not national averages or guaranteed schedules. They reflect published provider examples and patient guidance. The treating team confirms the individual plan, time needed near the clinic and fitness to travel. Waiting lists are not included.
Cytotoxic chemotherapy
Uses medicines that damage or inhibit dividing cells. The exact drug combination is chosen for the cancer type, stage and treatment goal. It may precede surgery, follow local treatment or control advanced disease. It differs from immunotherapy and targeted therapy.
- Time
- Repeated cycles; total duration is regimen-specific
- Appointments
- Blood tests & review before treatment
Immune checkpoint inhibitor therapy
Blocks signals that restrain immune responses, helping immune cells attack certain cancers. It is used only for eligible tumour types and stages; biomarker testing may be required. It is not a general immune booster or a treatment for every cancer.
- Time
- Repeated administrations; duration varies
- Appointments
- Drug example: every 3 or 6 weeks
Implanted venous access port
Durable access for systemic treatment.
- Time
- A planned insertion appointment includes preparation, placement and observation.
- Appointments
- Assessment + operation + follow-up
Can’t find your treatment?
Tell us the specialty or service you need. We can clarify the next coordination step.
Clinical terms
Use these clinical terms when discussing a referral or looking for a provider. Focused care areas may sit within a broader medical specialty.
- Systemic cancer therapies
- Systemische TumortherapieGermanSystémová protinádorová léčbaCzech
Treatments & services
Explore specific procedures, investigations and care services. The clinical team confirms which options fit the individual case.
Cytotoxic chemotherapy
Drug treatment of selected cancers.
Immune checkpoint inhibitor therapy
Immunotherapy for eligible tumours.
Molecularly targeted therapy
Treatment matched to tumour characteristics.
Endocrine therapy for cancer
Treatment of hormone-sensitive tumours.
Molecular tumour profiling
Selected biomarkers for treatment decisions.
Implanted venous access port
Durable access for systemic treatment.
Can’t find your treatment?
Tell us the specialty or service you need. We can clarify the next coordination step.
Planning your care
Ask the treating service for a written plan. Appointment numbers and time away depend on the procedure, results and individual needs.
- Does the team need pathology, staging or biomarker review before recommending treatment?
- Ask for a written calendar distinguishing treatment sessions or cycles, blood tests, review visits and possible inpatient care.
- Which symptoms need urgent attention, and who will provide support between treatments and after returning home?
Sources & availability
These references provide clinical background. The guide is not a confirmed service menu for every centre or both countries, and cited organisations are not necessarily RAUQ partners. Confirm eligibility, availability and international patient access with the centre.
Guide content and sources checked 29 October 2026.